Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 219 M246 M241 M251 M236 M 974 M Research & development ————— — Operating income -525 M-316 M234 M-223 M-304 M -609 M Non-Operating Income, Total -4 M-7 M1 M13 M32 M 39 M Interest expense, net of interest capitalized 287 M404 M268 M204 M275 M 1.15 B Non-Operating Income, excl. Interest Expenses -287 M-404 M-268 M-204 M-245 M -1.12 B Unusual income/expense -4 M-7 M1 M13 M2 M 9 M Pretax income -525 M-316 M234 M-223 M-304 M -609 M Equity in earnings ————— — Taxes -82 M-22 M50 M-29 M29 M 28 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -443 M-294 M184 M-194 M-333 M -637 M Discontinued operations ————— — Net income -443 M-294 M184 M-194 M-333 M -637 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -443 M-294 M154 M-198 M-333 M -671 M Basic earnings per share (Basic EPS) -1.44-0.950.59-0.61-1.06 -2.03 Diluted earnings per share (Diluted EPS) -1.44-0.950.42-0.46-1.06 -2.05 Average basic shares outstanding 307 M309 M311 M310 M314 M — Diluted shares outstanding 307 M309 M364 M322 M314 M — EBITDA 60 M148 M741 M373 M222 M 1.48 B EBIT -525 M-316 M234 M-223 M-304 M -609 M Cost of revenue 1.81 B1.81 B1.91 B1.89 B1.82 B 7.43 B Other cost of goods sold 1.27 B1.39 B1.45 B1.37 B1.34 B 5.56 B Depreciation & amortization (cash flow) 585 M464 M507 M596 M526 M 2.09 B